REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,137 | -53.0% | 99,129 | +3.6% | 0.00% | -60.0% |
| Q2 2023 | $2,421 | -15.3% | 95,651 | +7.8% | 0.01% | -16.7% |
| Q1 2023 | $2,859 | +74.4% | 88,768 | -0.1% | 0.01% | +50.0% |
| Q4 2022 | $1,639 | -99.9% | 88,819 | +17.1% | 0.00% | -20.0% |
| Q3 2022 | $2,047,000 | +351.9% | 75,825 | +131.1% | 0.01% | +400.0% |
| Q2 2022 | $453,000 | -23.4% | 32,813 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $591,000 | +46.7% | 30,313 | +22.7% | 0.00% | 0.0% |
| Q4 2021 | $403,000 | -31.6% | 24,715 | +16.8% | 0.00% | 0.0% |
| Q3 2021 | $589,000 | +31.5% | 21,160 | +39.8% | 0.00% | 0.0% |
| Q2 2021 | $448,000 | +4.9% | 15,137 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $427,000 | +14.5% | 15,285 | +16.0% | 0.00% | 0.0% |
| Q4 2020 | $373,000 | +18.0% | 13,182 | +4.7% | 0.00% | 0.0% |
| Q3 2020 | $316,000 | – | 12,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |